Oric Pharmaceuticals, Inc. (ORIC)
NASDAQ · Manufacturing · Pharmaceutical preparations
ORIC price, last 12 months
Key stats
- Previous close
- $7.65
- Open
- $7.86
- Day range
- $7.53 – $7.98
- 52-week range
- $7.23 – $14.68
- Volume
- 1.1M
- Avg volume (20 days)
- 2M
- Market cap
- $814.7M
Performance
Technicals and fundamentals
About Oric Pharmaceuticals, Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $814.7M